India's biopharmaceutical industry is at the cusp of a transformation driven by technology, and a renewed focus on innovation. To sustain and accelerate this growth, cross-sectoral collaboration is the key.
Biopharma Synergy: Connecting Innovation and Growth is a high-impact, curated platform that brings together leaders from biopharma, biotech, digital health, manufacturing, to explore how advanced technologies such as AI/ML, next-gen biomanufacturing, and regulatory framework can shape the future of healthcare and life sciences in India.
With the BioE3 Policy opening new doors for biomanufacturing, and digital innovation becoming core to R&D, this event will spotlight the most pressing challenges, pioneering solutions, and opportunities for synergy across the biopharma value chain. Whether you're steering R&D, leading digital transformation, this platform offers unparalleled insights, real-world case studies, and collaboration opportunities to keep you at the forefront of industry evolution. This premier gathering is a strategic convergence of visionaries, scientists, technologists, and business leaders shaping the future of biopharmaceutical innovation.
Vice President, India
Life Sciences Innovations Group (LSIG), Danaher India
EVP,
Stallion Labs Pvt. Ltd.
PhD, Head, In Vitro Biology, Drug Discovery Research,
Zydus Research Centre
Senior General Manager – Global Program Management, Intas Pharmaceuticals (Biopharma Division)
Director,
Kashiv Biosciences
Founder and CEO,
Protein Advanced Analytics Pvt Ltd
Founder & CEO,
Ortiv-Q3 Research Pvt. Ltd.
CEO
AIC-LMCP Foundation
Country Leader, Sales & Marketing – India & SWA, Beckman Coulter Life Sciences
President, CRO
Cadila Pharmaceuticals Limited
General Manager,
Intas pharmaceutical
Business Manager,
Beckman Coulter Life Sciences
Cell Culture Product Manager – India, Cytiva
Lead Platform Product Manager, Next Gen and AI, IDBS
.pdf.png/:/rs=h:114,cg:true,m/qt=q:95)
.pdf.png/:/rs=h:104,cg:true,m/qt=q:95)